Loading data for BIB — first visit, this takes a few seconds.
ProShares Ultra Nasdaq Bi... (BIB)
NasdaqGM: BIB
· Real-Time Price · USD
116.60
+0.29 (0.25%)
At close: Aug 28, 2026, 3:56 PM
116.56
-0.09%
After-hours: 4:15 PM
The price, the headline numbers and the latest news, in one place.
ProShares Ultra Nasdaq Biotechnology (BIB) Stock Price, Analysis & Data
0.25% (1D)
| Bid | 98.19 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| n/a | |
| n/a | |
| 33.02 | |
| n/a | |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 105.06 |
| Volume | 6,776 |
| Avg. Volume (20D) | 12,023 |
| Open | 116.20 |
| Previous Close | 116.31 |
| Day's Range | 113.31 - 116.27 |
| 52-Week Range | 55.34 - 126.40 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BIB
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified....
Industry n/a
Sector n/a
IPO Date Apr 9, 2010
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol BIB
Financial Performance
In undefined, ProShares Ultra Nasdaq Biotechnology's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements